Clinical Trial Detail

NCT ID NCT01391533
Title Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sanofi
Indications

lung non-small cell carcinoma

Advanced Solid Tumor

Therapies

SAR125844

Age Groups: adult

No variant requirements are available.